Article Text
Image of the moment
Localised chiasmal optic neuritis in neuromyelitis optica spectrum disorder
Statistics from Altmetric.com
Footnotes
Contributors All authors contributed to data collection, analysis, drafting, and review of this manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned. Externally peer reviewed by Christian Lueck, Canberra, Australia.
Read the full text or download the PDF:
Other content recommended for you
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS
- Optic neuritis with potential for poor outcome
- SLE presenting as demyelinative autoimmune visual loss
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Acute neurological visual loss in young adults: causes, diagnosis and management
- Assess and interpret the visual fields at the bedside
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Seronegative neuromyelitis optica spectrum disorder: severe polysymptomatic presentation with successful treatment response
- Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies
- CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications